The significance of magnesium in cardiac arrhythmias;Der stellenwert von magnesium bei herzrhythmusstorungen

Wiener Medizinische Wochenschrift

Volumn 150, Issue 15-16, 2000, Pages 330-334

  Stuhlinger, H G ^a   Kiss, K ^a   Smetana, R ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Arrhythmias; Magnesium

Indexed keywords

ANTIARRHYTHMIC AGENT; MAGNESIUM; NEUROLEPTIC AGENT; TRICYCLIC ANTIDEPRESSANT AGENT;

ARTICLE; ATRIOVENTRICULAR CONDUCTION; DIGITALIS INTOXICATION; DRUG EFFICACY; DRUG INDICATION; DRUG OVERDOSE; HEART ARRHYTHMIA; HEART VENTRICLE EXTRASYSTOLE; HEART VENTRICLE FIBRILLATION; HUMAN; PERIOPERATIVE PERIOD; SINUS RHYTHM; SUPRAVENTRICULAR TACHYCARDIA; TORSADE DES POINTES;

ADMINISTRATION, ORAL; ANTI-ARRHYTHMIA AGENTS; ARRHYTHMIA; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; INFUSIONS, INTRAVENOUS; MAGNESIUM; PERIOPERATIVE CARE; PRACTICE GUIDELINES; RANDOMIZED CONTROLLED TRIALS; TACHYCARDIA;

EID: 0033773370     PISSN: 00435341     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (69)

1. Magnesium sulfate therapy for sustained monomorphic ventricular tachycardia
2. Intravenous magnesium for the treatment of cardiac arrhythmias
3. Magnesium therapy for refractory ventricular fibrillation
4. Magnesium sulfate in paroxysmal tachycardia
5. Magnesium therapy in new onset atrial fibrillation
6. Limited effectiveness of magnesium infusions for suppressing inducible sustained monomorphic ventricular tachycardia
7. Hypomagnesemia in heart failure with ventricular arrhythmias. Beneficial effect of magnesium supplementation
8. Magnesium sulfate and digitalis-toxic arrhythmias
9. Resuscitation from prolonged cardiac arrest with high dose intravenous magnesium sulfate
10. Serum magnesium levels in symptomatic atrial fibrillation and their relation to rhythm control by intravenous digoxin
11. Effects of magnesium sulfate on cardiac conduction and refractoriness in humans
12. Potassium/magnesium depletion in patients with cardiovascular disease
13. Ventricular extrasystoles and intracellular electrolytes before and after potassium and magnesium infusions in patients on diuretic treatment
14. Clinical and prognostic significance of serum magnesium concentration in patients with severe chronic congestive heart failure: The PROMISE Study
15. Guidelines for cardiopulmonary resuscitation and emergency cardiac care - Part III: Adult advanced cardiac life support
16. Magnesium administration and dysrhythmias after cardiac surgery. A placebo-controlled double-blind trial
17. Magnesium in cardiac arrest (the magic trial)
18. Magnesium and the heart: Antiarrhythmic therapy with magnesium
19. Die wirkung einer oralen magnesium-supplementation auf ventrikulare arrhythmien und parameter des magnesiumstoffwechsels
20. Magnesium therapy in massive digoxin intoxication
21. The effect of oral magnesium, alone or as an adjuvant to sotolol, after cardioversion in patients with persistent atrial fibrillation
22. Effectiveness of magnesium chloride in the treatment of ventricular tachyarrhythmias due to digitalis intoxication
23. Prognostic importance of the serum magnesium concentration in patients with congestive heart failure
24. Is oral magnesium replacement antiarrhythmic in patients with congestive heart failure?
25. Effects of intravenous magnesium sulfate on arrhythmias in patients with congestive heart failure
26. The effect of magnesium versus verapamil on supraventricular arrhythmias
27. Effect of magnesium sulfate on ventricular rate control in atrial fibrillation
28. Electrophysiologic and antiarrhythmic effects of magnesium in patients with inducible ventricular tachyarrhythmia
29. Hochdosierte orale magnesiumtherapie bei herzrhythmusstorungen
30. Ionic biology and ionic medicine in cardiac arrhythmias with particular reference to magnesium
31. Magnesium and potassium therapy in multifocal atrial tachycardia
32. Magnesium and dysrhythmias
33. Magnesium substitution and postoperative arrhythmias in patients undergoing coronary artery bypass grafting
34. Depressant effect of magnesium on early afterdepolarisations and triggered activity induced by cesium, quinidine and 4-aminopyridine in canine cardiac Purkinje fibers
35. Magnesium therapy in ventricular arrhythmias
36. Magnesium sulfate in the treatment of ventricular arrhythmias due to digoxin toxicity
37. Magnesium sulphate in the treatment of ventricular fibrillation in amitryptiline poisoning
38. Case report: Reversible QT prolongation with torsades de pointes in a patient with pimozide intoxication
39. Electrophysiologic effects of intravenous magnesium in patients with normal conduction systems and no clinical evidence of significant cardiac disease
40. Die bedeutung von magnesium in der intensivmedizin
41. Luderitz B: Magnesium: Einfluβ einer hochdosierten intravenosen applikation auf monomorphe ventrikulare Tachykardien
42. Intravenous treatment with magnesium in recurrent persistent ventricular tachycardia
43. Arrhythmogener effekt von flecainid - Therapie mit magnesium i.v.
44. Parenteral magnesium sulfate versus amiodarone in the therapy of atrial tachyarrhythmias: A prospective randomized study
45. A double blind randomized trial of magnesium sulfate for ventricular tachycardia
46. Ventricular arrhythmia suppression by magnesium treatment after coronary artery bypass surgery
47. Efficacy of magnesium sulfate in the treatment of torsades de pointes
48. Torsades de pointes ventricular tachycardia associated with overdose of astemizole
49. Magnesium deficiency in a medical icu population
50. Prospective evaluation of parenteral magnesium sulfate in the treatment of patients with reentant AV supraventricular tachycardia
51. 'Les torsades de pointes': An unusual ventricular arrhythmia
52. Polymorphous ventricular tachycardia associated with normal and long QT intervals
53. Arrhythmia prophylaxis after coronary artery bypass grafting: Regimens of magnesium sulfate administration
54. Modulation of cardiac impulse generation and conduction by nifedipine and verapamil analyzed by a refined surface ECG technique in Langendorff perfused guinea pig hearts
55. Effect of acute magnesium administration on the frequency of ventricular arrhythmia in patients with heart failure
56. The action of magnesium on the heart
57. Randomised trial of magnesium in in-hospital cardiac arrest. Duke internal medicine housestaff
58. Successful resuscitation and neurologic recovery from refractory ventricular fibrillation after magnesium sulfate administration
59. Limited effect of magnesium sulfate on torsades de pointes ventricular tachycardia
60. Treatment of torsade de pointes with magnesium sulfate
61. Magnesium therapy for torsades de pointes
62. Suppression of ventricular arrhythmias by magnesium
63. Clinical and electrophysiological effects of magnesium sulfate on paroxysmal supraventricular tachycardia and comparison with adenosine triphosphate
64. Effect of intravenous magnesium sulfate on supraventricular tachycardia
65. A high prevalence of hypomagnesemia and hypermagnesemia in hospitalized patients
66. Antiarrhythmic effects of increasing the daily intake of magnesium and potassium in patients with frequent ventricular arrhythmias
67. Magnesiummangel und magnesiumsubstitution. Einfluss auf ventrikulare herzrhythmusstorungen unterschiedlicher athiologie
68. Magnesium als antiarrhythmisches therapieprinzip bei supraventrikularen und ventrikularen Herzrhythmusstorungen
69. Uber die Magnesiumwirkung auf das Herz